Notice of Change to Key Dates for RFA-NS-25-025: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)
Notice Number:
NOT-NS-25-026
Key Dates
Release Date:
September 9, 2025
Related Announcements
- November 13, 2024 - Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed). See NOFO RFA-NS-25-025.
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this notice is to inform applicants of a receipt date change for RFA-NS-25-025, Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed).
Changes to the Part 1. Overview Information, Key Dates section are in bold italics below.
Part 1. Overview Information
Key Dates
Currently Reads:
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| March 03, 2025 | March 03, 2025 | Not Applicable | July 2025 | October 2025 | December 2025 |
| October 03, 2025 | October 03, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
Revised to read:
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| March 03, 2025 | March 03, 2025 | Not Applicable | July 2025 | October 2025 | December 2025 |
| November 14, 2025 | November 14, 2025 | Not Applicable | March 2026 | May 2026 | July 2026 |
Expiration Date: November 15, 2025
All other aspects of the NOFO remain unchanged.
Inquiries
Please direct all inquiries to:
Glen Nuckolls, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5876
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
